Prosecution Insights
Last updated: October 02, 2026

Examiner: DIOP, FATIMATA SAHRA

Tech Center 3700 • Art Units: 3781 3783

This examiner grants 69% of resolved cases

Analysis

Fatimata Sahra Diop has resolved 86 cases in Art Unit 3781 within Tech Center 3700. The examiner's allowance rate is 68.6%, and the median days to allowance is 1428. The interview lift of 38.0% is substantial, suggesting that interviews are highly effective at securing an allowance and overcoming initial rejections. This profile indicates that while the timeline is long, success is very achievable through direct engagement. The 38.0% lift is a critical factor for practitioners to consider when planning their strategy.

Practitioners in Tech Center 3700 should consider interviews as a primary strategy, given the 38.0% lift. This can significantly improve the 68.6% baseline allowance rate. The 1428-day median to allowance is a lengthy process, so applicants should be prepared for an extended timeline. Although the 86 resolved cases represent a smaller sample, the high interview lift is a strong indicator of the examiner's receptiveness to verbal communication. By leveraging the 38.0% lift, practitioners can more effectively navigate the 1428-day path to allowance and secure a favorable outcome. The 86 resolutions provide a clear roadmap for success in Art Unit 3781.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

68.6%
Allow Rate
-1.4% vs TC avg
116
Total Applications
+38.0%
Interview Lift
1428
Avg Prosecution Days
Based on 86 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
24.5%
§102 Novelty
61.0%
§103 Obviousness
12.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18593431 Rapidly Insertable Central Catheters Including Catheter Assemblies and Methods Thereof Final Rejection Bard Access Systems, Inc.
18095968 Introducer Needles, Catheter Insertion Assemblies, and Methods Thereof Final Rejection Bard Access Systems, Inc.
18727623 AN IMPLANTABLE CLOSED-LOOP SYSTEM FOR MONITORING AND TREATMENT Non-Final OA Massachusetts Institute of Technology
17665165 TECHNIQUES AND DEVICES FOR ADAPTATION OF MAXIMUM DRUG DELIVERY LIMITS Final Rejection Insulet Corporation
18009467 MEDICAMENT DELIVERY DEVICE Non-Final OA SHL MEDICAL AG
17602148 DRUG DELIVERY DEVICE WITH SMART GRIP Non-Final OA AMGEN INC.
18934220 PRESSURE WAVE SYRINGE DEVICE Final Rejection SANUWAVE, INC.
17612489 MEDICAL HOLLOW ARTICLE, MEDICAL HOLLOW ARTICLE HAVING A CLOSURE CAP, METHOD FOR PRODUCING A MEDICAL HOLLOW ARTICLE, AND KIT Final Rejection Vetter Pharma-Fertigung GmbH & Co. KG
18749711 LIQUID MEDICINE INJECTION DEVICE Non-Final OA IPV
18292454 APPLICATION APPARATUS FOR AT LEAST ONE IMPLANT Non-Final OA AMW GMBH
17286987 Drug Delivery Devices and Systems for Local Drug Delivery to the Upper Urinary Tract Non-Final OA Jannsen Biotech, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month